Table 2 Life expectancy (LE), health-adjusted life expectancy (HALE) (with 95% confidence intervals), and years lost in LE and HALE at selected ages, by diabetes (DM) status and sex, Canada, 2004-2006 1
From: Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada
Sex | Measure | Total population (I) | Without DM (II) | With DM (III) | Loss of LE associated with DM (II-III) | Gain in LE after eliminating DM (II-I) |
|---|---|---|---|---|---|---|
At birth | ||||||
Females | LE | 83.6(83.6-83.7) | 85.0(85.0-85.1) | 74.9(74.3-75.6) | 10.1*(9.5-10.7) | 1.4* |
HALE | 72.1(71.8-72.3) | 73.3(73.0-73.5) | 62.2(60.7-63.8) | 11.1*(9.5-12.7) | 1.2* | |
LE-HALE2 | 11.7* (11.4-12.0) | 12.7*(11.8-13.6) | ||||
(LE-HALE)/LE3 | 0.14 | 0.17 | ||||
Males | LE | 78.9(78.8-78.9) | 80.2(80.2-80.3) | 70.9(70.4-71.4) | 9.3*(8.8-9.8) | 1.3* |
HALE | 69.6(69.4-69.9) | 70.9(70.7-71.2) | 60.1(58.4-61.9) | 10.8*(9.1-12.5) | 1.3* | |
LE-HALE2 | 9.3*(9.1-9.5) | 10.8*(9.6-12.0) | ||||
(LE-HALE)/LE3 | 0.12 | 0.15 | ||||
At age 20 | ||||||
Females | LE | 64.3(64.2-64.3) | 65.7(65.7-65.7) | 56.5(56.2-56.8) | 9.2*(8.9-9.5) | 1.4* |
HALE | 53.6(53.3-53.9) | 54.8(54.5-55.1) | 44.7(43.4-46.1) | 10.1*(8.7-11.5) | 1.2* | |
LE-HALE2 | 10.9*(10.6-11.2) | 11.8*(10.8-12.8) | ||||
(LE-HALE)/LE3 | 0.17 | 0.21 | ||||
Males | LE | 59.6(59.6-59.7) | 61.0(61.0-61.1) | 52.2(51.9-52.5) | 8.8*(8.5-9.1) | 1.4* |
HALE | 51.3(51.1-51.6) | 52.6(52.3-52.9) | 43.0(41.9-44.1) | 9.6*(8.5-10.7) | 1.3* | |
LE-HALE2 | 8.4*(8.2-8.6) | 9.2*(8.4-10.0) | ||||
(LE-HALE)/LE3 | 0.14 | 0.18 | ||||
At age 55 | ||||||
Females | LE | 30.6(30.6-30.6) | 32.0(31.9-32.0) | 26.0(25.9-26.1) | 6.0*(5.9-6.1) | 1.4* |
HALE | 23.6(23.4-23.9) | 24.7(24.4-25.0) | 18.9(18.3-19.6) | 5.8*(5.1-6.5) | 1.1* | |
LE-HALE2 | 7.3*(7.1-7.5) | 7.1*(6.5-7.7) | ||||
(LE-HALE)/LE3 | 0.23 | 0.27 | ||||
Males | LE | 26.8(26.7-26.8) | 28.0(28.0-28.1) | 23.0(23.0-23.1) | 5.0*(4.9-5.1) | 1.2* |
HALE | 21.6(21.4-21.8) | 22.8(22.5-23.1) | 17.5(17.0-18.1) | 5.3*(4.7-5.9) | 1.2* | |
LE-HALE2 | 5.2*(5.0-5.4) | 5.5*(5.0-6.0) | ||||
(LE-HALE)/LE3 | 0.19 | 0.24 | ||||
At age 80 | ||||||
Females | LE | 11.0(10.9-11.0) | 11.7(11.7-11.7) | 9.1(9.1-9.2) | 2.6*(2.6-2.6) | 0.7* |
HALE | 7.0(6.7-7.2) | 7.4(7.1-7.7) | 5.8(5.2-6.3) | 1.6*(0.9-2.3) | 0.4* | |
LE-HALE2 | 4.3*(4.0-4.6) | 3.3*(2.8-3.8) | ||||
(LE-HALE)/LE3 | 0.37 | 0.36 | ||||
Males | LE | 8.8(8.7-8.8) | 9.4(9.3-9.4) | 7.5(7.4-7.5) | 1.9*(1.9-1.9) | 0.6* |
HALE | 5.9(5.6-6.2) | 6.4(6.1-6.8) | 4.3(3.7-5.0) | 2.1*(1.4-2.8) | 0.5** | |
LE-HALE2 | 3.0*(2.7-3.3) | 3.2*(2.6-3.8) | ||||
(LE-HALE)/LE3 | 0.32 | 0.43 | ||||